Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
Year: 1997
Type: article
Source: Biochemical Society Transactions
DOI: 10.1042/bst0250705
Authors: D. R. Anderson, A. Grillo-López, C. Varns, K. S. Chambers, N. Hanna
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W27919971
